Literature DB >> 31907422

A decade of optimizing drug development for rare neuromuscular disorders through TACT.

Kathryn R Wagner, Annamaria De Luca, Didier Caizergues, James Dowling, Nathalie Goemans, Heather Gordish-Dressman, Miranda D Grounds, Michael Kelly, Anna Mayhew, Elizabeth M McNally, Tracey Zoetis, Joanne Lee, Cathy Turner, Dominic J Wells, Cristina Csimma, Volker Straub.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31907422     DOI： 10.1038/d41573-019-00199-1

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice.

Authors:  Raffaella Willmann; Annamaria De Luca; Michael Benatar; Miranda Grounds; Judith Dubach; Jean-Marc Raymackers; Kanneboyina Nagaraju
Journal:  Neuromuscul Disord       Date:  2011-07-06       Impact factor: 4.296
  1 in total
  3 in total

1.  The predictive value of models of neuromuscular disorders to potentiate clinical translation.

Authors:  Maaike van Putten
Journal:  Dis Model Mech       Date:  2022-08-01       Impact factor: 5.732

Review 2.  Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT).

Authors:  Raffaella Willmann; Joanne Lee; Cathy Turner; Kanneboyina Nagaraju; Annemieke Aartsma-Rus; Dominic J Wells; Kathryn R Wagner; Cristina Csimma; Volker Straub; Miranda D Grounds; Annamaria De Luca
Journal:  Dis Model Mech       Date:  2020-02-07       Impact factor: 5.758

3.  Moving neuromuscular disorders research forward: from novel models to clinical studies.

Authors:  Maaike van Putten; Julija Hmeljak; Annemieke Aartsma-Rus; James J Dowling
Journal:  Dis Model Mech       Date:  2020-02-25       Impact factor: 5.758
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.